홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Gemcitabine Hydrochloride

HCID 60749
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
122111-03-9
표준 SMILES
Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1
InChIKey
OKKDEIYWILRZIA-OSZBKLCCSA-N
분자식
C9H12ClF2N3O4
평균 분자량
299.66 g/mol
단동위원소 질량
299.0484399

개요

Gemcitabine Hydrochloride is the hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.

이름 및 식별자

우선 이름
Gemcitabine Hydrochloride
IUPAC
4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
영어명
Gemcitabine hydrochloride
분자식
C9H11F2N3O4.ClH
분자량
299.66

이름 및 동의어

GEMCITABINE HYDROCHLORIDE122111-03-9Gemcitabine HClLY188011 hydrochlorideGemcitabine HCI2'-Deoxy-2',2'-difluorocytidine monohydrochlorideINFUGEM2'-deoxy-2',2'-difluorocytidine hydrochlorideGemcitabine (as hydrochloride)Cytidine, 2'-deoxy-2',2'-difluoro-, monohydrochlorideDTXSID30478492',2'-Difluorodeoxycytidine monohydrochloride
이름 더 보기
gemzarGecitabine2',2'-DIFLUORO-2'-DEOXYCYTIDINE4-amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1h-pyrimidin-2-one hydrochlorideDFDCDDFCDFDCYDGeMsarT11YSY
U347PV74ILLY-188011 HYDROCHLORIDEDTXCID3027827NSC613327FF 10832CHEBI:31647RefChem:57768FF10832

데이터베이스 식별자

CAS

물성

구조 계산 물성

극성 표면적
108 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
6
회전 가능 결합 수
2
무거운 원자 수
19
형식 전하
0
복잡도
426

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
250 °C · >250°C dec.
저장 조건
2 · 2-8°C
용해도
2 O: · H2O: ≥10mg/mL
물리적 상태
백색분말
산도 계수 (pKa)
3.58 · 3.58 (acidic)
색상
하얀색
수용성
25 mg/mL · water: 25mg/mL
Merck
14 · 14,4386
안정성
1 · 제공된 대로 구매일로부터 1년 동안 안정적입니다. DMSO 또는 증류수 용액은 -20°에서 최대 1개월 동안 보관할 수 있습니다.
InChI
InChI=1/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/s3
InChIKey
OKKDEIYWILRZIA-LJAFHONQNA-N
SMILES
[C@H]1(O[C@@H]([C@@H](O)C1(F)F)CO)N1C=CC(N)=NC1=O.Cl |&1:0,2,3,r|

화학적 성질

White crystalline granular, odorless

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H302 (11.3%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P302+P352, P305+P351+P338, P317, P318, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 62 reports by companies from 17 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 4 (11.3%)

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Gemcitabine hydrochloride

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

안전 데이터

wgk
3
rtecs
HA3840000
HS 번호
29420000
risk_code
21-36/38-46-62-63
hazard_code
Xn,Xi
safety_code
25-26-36/37-53
Hazard Classifications
Repr. 1B
스토리지 클래스
6.1C - Combustible, acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

FDA Pharmacological Classification · 2건

GEMCITABINE HYDROCHLORIDE

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

MeSH Pharmacological ClassificationAntimetabolites that are useful in cancer chemotherapy.
응용 분야 · 1건

개요Gemcitabine is a novel nucleoside analog that was launched in 1995 in the Netherlands for the treatment of non-small cell lung cancer (nsclc) and in Sweden for pancreatic cancer. Gemcitabine is a prodrug which is phosphorylated intracellularly by deoxycytadine kinase to its active forms, the di- and triphosphates which bind to DNA competitively. This insertion inhibits processes required for DNA synthesis and metabolism, the essential function for both cell replication and repair. Furthermore, gemcitabine displays an extraordinary array of self-potentiating mechanisms that increase the concentration and prolong the retention of its active nucleotides in tumor cells. The title compound has shown activity against a wide spectrum of human solid tumors including colon, mammary, breast, bladder cancers. Synergistic activity of gemcitabine with other anticancer agents such as cisplatin has been reported.

상·하류 제품 정보

하류 제품

4-Amino-1-(2-deoxy-2,2-difluoro-a-D-erythro-pentofuranosyl)-2(1H)-pyrimidinone Hydrochloride아세라린2',2'-Difluoro-2'-deoxyuridine
추가 설명 · 1건

관련 반응

18건
반응 기록 만들기
HRID 217106 반응식
HRID 217106생성물로
HRID 217107 반응식
HRID 217107생성물로
HRID 241530 반응식
HRID 241530반응물로
HRID 241531 반응식
HRID 241531반응물로
HRID 241533 반응식
HRID 241533반응물로
HRID 493017 반응식
HRID 493017반응물로
HRID 982161 반응식
HRID 982161반응물로
HRID 982162 반응식
HRID 982162반응물로
이전1 / 3 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
122111-03-9
PubChem CID
60749
DTXSID
DTXSID3047849
ChEMBL
CHEMBL1637
UNII
U347PV74IL
EC Number
601-823-3

정의ChEBI: A 2'-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic ca cer, bladder cancer and breast cancer.